Company Filing History:
1 out of 93 
1 out of 3 Years Active: 2012
Title: Inventor Sébastien Santini: A Pioneer in Leukotriene Research
Introduction
Sébastien Santini, based in Ollieres, France, is an inventor renowned for his contributions to the understanding and application of leukotriene research. With one patent to his name, his work focuses on a critical area of biochemistry that may have far-reaching implications in treating diseases affecting both animals and humans.
Latest Patents
Santini holds a significant patent titled "Leukotriene B4 binding soluble lipocalin receptor from Ixodes ricinus." This innovative polypeptide, derived from Ixodes ricinus, encompasses the polynucleotide encoding for the Leukotriene B4 polypeptide. Importantly, these polypeptides have potential applications as research reagents as well as diagnostics and treatments specific to various animal and human diseases.
Career Highlights
Throughout his career, Sébastien Santini has been affiliated with esteemed institutions such as Université Libre De Bruxelles and Faculté Universitaire Des Sciences Agronomiques De Gembloux. His experience in these environments has nurtured his capabilities, allowing him to innovate continually in the field of biochemistry and therapeutic research.
Collaborations
Santini has collaborated with several notable professionals in his field, including Edmond Godfroid and Jérôme Beaufays. Working alongside these experts has not only enhanced his research but also contributed to the broader scientific community's understanding of leukotrienes and their implications for health.
Conclusion
Sébastien Santini represents an impactful figure in the realm of biochemistry, specifically concerning leukotriene research. His pioneering patent and collaborations highlight his commitment to advancing medical science, potentially improving diagnostics and treatments for diseases. As research continues to evolve, Santini's contributions will undoubtedly influence future innovations in this crucial field.